Afuco™ Anti-Human EMP2 ADCC Recombinant Antibody (PG-101), ADCC Enhanced

CAT#: AFC-219CL

Anti-EMP2 ADCC Enhanced Antibody (PG-101) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel IgG1 monoclonal antibody to EMP2, PG-101 treatment in the primary tumor is sufficient to reduce secondary tumor formation in triple negative breast cancer cells on the order of 1:20, 000 compared to the control treated mice. PG-101 in combination with docetaxel can cure up to 80% of animals treated. This effect is lasting as these mice have shown no rebound in tumor load more than 2 months following the last treatment. Collectively, these results show that PG-101 therapy has the potential to revolutionize the outcomes for women with breast cancer.

Gene Expression
Figure 1 IF staining of human cell line U-251 MG Figure 2 IHC staining of human lung Figure 3 IF staining of human cell line A-431 Figure 4 Cerebral cortex Figure 5 Lung Figure 6 Colon Figure 7 Kidney Figure 8 Lymph node Figure 9 RNA cell line category: Cell line enhanced (MCF7, RT4, SK-BR-3, T-47d)

Specifications

  • Host Species
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Cancer

Product Property

  • Purity
  • >95% as determined by analysis by SDS-PAGE
  • Storage
  • Store at –20 or -70°C upon receipt. Divide antibody into aliquots prior usage and avoid multiple freeze-thaw cycles.

Target

  • Alternative Names
  • EMP2; epithelial membrane protein 2; XMP; NPHS10; EMP-2
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-219CL. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "EMP2"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOB-317 Recombinant Anti-human EMP2 Antibody WB, Neut, FuncS IgG
CAT Product Name Application Type
MOB-317-F(E) Recombinant Anti-human EMP2 Antibody Fab Fragment IP, IF, FuncS Fab
CAT Product Name Application Type
MOB-317-S(P) Recombinant Anti-human EMP2 Antibody scFv Fragment ELISA, IP, FuncS scFv
CAT Product Name Application Type
TAB-231CL Human Anti-EMP2 Recombinant Antibody (TAB-231CL) ELISA Human IgG1
CAT Product Name Application Type
VS-0425-YC177 Recombinant Anti-EMP2 Vesicular Antibody, EV Displayed (VS-0425-YC177) ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare